Effect of Essential Phospholipids in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial

Authors

Institutions

Publication Details

Journal
Liver International
Published
2026-03-26
DOI
https://doi.org/10.1111/liv.70601
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Essential Phospholipids in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial

Norbert Stefan, Marek Hartleb, Béatrice Bois De Fer, Branko Popović et al.
Liver International
Liver Disease Diagnosis and Treatment
article

Effect of Essential Phospholipids in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial

Norbert Stefan, Marek Hartleb, Béatrice Bois De Fer, Branko Popović, J Gietka, Rafael Varona, Münevver Demir, Jiangao Fan, Łukasz Bułdak, Jörn M. Schattenberg
article en

Abstract

No abstract available for this paper.
Liver InternationalVol. 46(5)
Hôpital américain de paris (FR), Medical University of Silesia (PL), Shanghai Jiao Tong University (CN), XinHua Hospital (CN), Clariant (Germany) (DE), University Children's Hospital Tübingen (DE), 1 Military Clinical Hospital with Outpatient Clinic (PL), Charité - Universitätsmedizin Berlin (DE), Saarland University (DE)
Good health and well-being
Openalex Percentile: Top 7%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effect of Essential Phospholipids in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial — Norbert Stefan, Marek Hartleb, et al. · Liver International (2026) | TGRS Research Map | TGRS